IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
The highest-rated healthcare stocks based on our 6-factor quantitative model. Ranked by composite score across quality, value, momentum, investment, stability, and short interest.
50 stocks shown · Updated hourly
We rank 50 healthcare stocks using our 6-factor quantitative model, and the results reveal an average composite score of 51.2/100 across the sector. 2 stocks earn a Buy or Strong Buy rating (bull/bear ratio: 2.0:1). The current leaders are AZN (61.4), SLGL (56.6), KMDA (56.3) — each demonstrating strength across quality, value, momentum, and stability factors. Below are the full rankings to help you identify the best quantitative opportunities in healthcare.
#1 ASTRAZENECA PLC (AZN) — Composite score: 61.4/100, rated Buy. AZN is a mega-cap healthcare company with a market cap of $311.3B. Its strongest factor is Momentum at 87/100.
#2 Sol-Gel Technologies Ltd. (SLGL) — Composite score: 56.6/100, rated Buy. SLGL is a micro-cap healthcare company with a market cap of $271M. Its strongest factor is Momentum at 98/100.
#3 KAMADA LTD (KMDA) — Composite score: 56.3/100, rated Hold. KMDA is a small-cap healthcare company with a market cap of $489M. Its strongest factor is Value at 75/100.
| # | Ticker | Rating | Composite |
|---|---|---|---|
| 1 | AZN | 61.4 | |
| 2 | SLGL | 56.6 | |
| 3 | KMDA | 56.3 | |
| 4 | PHAR | 55.3 | |
| 5 | NATR | 54.8 | |
| 6 | RPRX | 53.8 | |
| 7 | SEM | 53.6 | |
| 8 | MRK | 53.5 | |
| 9 | VMD | 53.4 | |
| 10 | THC | 53.1 | |
| 11 | INVA | 52.7 | |
| 12 | NHC | 52.5 | |
| 13 | GILD | 52.5 | |
| 14 | HOLX | 52.5 | |
| 15 | MD | 52.2 | |
| 16 | PBYI | 52.1 | |
| 17 | FONR | 51.8 | |
| 18 | ENSG | 51.7 | |
| 19 | JNJ | 51.7 | |
| 20 | UTHR | 51.4 | |
| 21 | APT | 51.3 | |
| 22 | INFU | 51.2 | |
| 23 | DGX | 51.1 | |
| 24 | BMY | 50.8 | |
| 25 | HCSG | 50.5 | |
| 26 | HCA | 50.5 | |
| 27 | DVA | 50.4 | |
| 28 | LIVN | 50.3 | |
| 29 | OCS | 50.3 | |
| 30 | AMRX | 50.3 | |
| 31 | UHS | 50.1 | |
| 32 | BIIB | 49.9 | |
| 33 | UTMD | 49.8 | |
| 34 | LH | 49.6 | |
| 35 | AMGN | 49.4 | |
| 36 | MSA | 49.3 | |
| 37 | IRMD | 49.3 | |
| 38 | PNTG | 49.3 | |
| 39 | LMAT | 49.1 | |
| 40 | EW | 49.1 | |
| 41 | PAHC | 48.9 | |
| 42 | PFE | 48.9 | |
| 43 | AMPH | 48.8 | |
| 44 | NVST | 48.7 | |
| 45 | REGN | 48.6 | |
| 46 | EHAB | 48.6 | |
| 47 | REGN | 48.6 | |
| 48 | NNNN | 48.5 | |
| 49 | TCMD | 48.5 | |
| 50 | MASI | 48.4 |
Based on our quantitative model, the top-rated healthcare stocks are ASTRAZENECA PLC (AZN, Buy, score: 61.4), Sol-Gel Technologies Ltd. (SLGL, Buy, score: 56.6), KAMADA LTD (KMDA, Hold, score: 56.3). These stocks rank highest on our composite metric combining quality, value, momentum, investment, stability, and short interest factors.
ASTRAZENECA PLC (AZN) is currently the #1 ranked healthcare stock in our model with a composite score of 61.4/100 and a Buy rating. It ranks #13 in our full universe of 4,439 stocks.
We currently rank 50 stocks in the Healthcare sector. Each stock is evaluated across six quantitative factors with an average composite score of 51.2/100 for the sector.
Each healthcare stock is scored on six factors: Quality (30% weight, measuring profitability), Momentum (25%, price trends), Value (15%, valuation), Investment (10%, capital allocation), Stability (10%, financial health), and Short Interest (10%, institutional positioning). The weighted composite score determines the final ranking.